Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Pandemic empties the coffers of SG’s hospitals
In Singapore, the coronavirus disease 2019 (COVID-19) pandemic has imposed a heavy financial burden on hospitals, driven mostly by the setting up of facilities and procurement of patient-care supplies, a new study has found.
Pandemic empties the coffers of SG’s hospitals
24 Dec 2021Statin adherence a must to reduce stroke risk among hyperlipidemia patients
Patients with hyperlipidemia who take their statin medication as prescribed appear to do well, with treatment adherence conferring significant protection against the risk of ischaemic and haemorrhagic strokes, as reported in a study.
Statin adherence a must to reduce stroke risk among hyperlipidemia patients
24 Dec 2021Repeat surgery plus chemo may improve survival in recurrent ovarian cancer
The DESKTOP* III trial has shown that patients whose ovarian cancer recurs have better overall survival (OS) following secondary cytoreductive surgery plus platinum-based chemotherapy compared with a platinum-based chemotherapy regimen alone.
Repeat surgery plus chemo may improve survival in recurrent ovarian cancer
23 Dec 2021Aumolertinib a win in EGFR T790M-positive advanced NSCLC
The novel third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) aumolertinib appears to be effective in the treatment of patients with EGFR T790M-positive advanced nonsmall cell lung carcinoma (NSCLC) following progression on first- and second-generation EGFR TKI therapy, according to data from the phase II APOLLO Registrational Trial.
Aumolertinib a win in EGFR T790M-positive advanced NSCLC
23 Dec 2021Time to prophylaxis linked to VTE incidence in traumatic brain injury patients
Most patients with traumatic brain injury receive delayed prophylaxis, with no association seen between incidence of venous thromboembolism (VTE) and prophylaxis regimen, suggests a study. However, a significant difference is observed in VTE incidence stratified by time to prophylaxis.
Time to prophylaxis linked to VTE incidence in traumatic brain injury patients
23 Dec 2021JAK inhibitors ritlecitinib, brepocitinib show promise against alopecia areata
Ritlecitinib and brepocitinib, both Janus kinase (JAK) inhibitors, show promising efficacy for the treatment of alopecia areata (AA), a new trial has found.